Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

28 January 2003

Pharmacokinetics studies and toxicity profile of raltitrexed used by intraperitoneal route in normothermia in a pig model.

Diem Nguyen, Claude Emond, Yves E. Leclerc, Igor Sherman, Pierre Dubé

Med Sci Monit 2003; 9(1): BR37-42 :: ID: 4786

Abstract

BACKGROUND: To define the pharmacokinetic and toxicity profile of raltitrexed administered by intraperitoneal route in a normothermic pig model. MATERIAL/METHODS: Twenty-one female pigs were divided in three groups. Under general anesthesia, pigs in groups 1 and 2 underwent laparotomy with resection of a small hepatic wedge, bowel anastomosis and portal and systemic vein catheterization. This was followed by an intraperitioneal delivery of raltitrexed: a dose of 1 mg was given to group 1 pigs, whereas group 2 received 2 mg. Serial sampling of portal blood, systemic blood and peritoneal fluid was then undertaken in both groups for pharmacokinetics studies. Pigs were followed daily for a period of 10 days after surgery with recordings of signs of toxicity. On day 10, an exploratory laparotomy was undertaken on each pig in order to assess peritoneal toxicity after which they were euthanized. Pigs in group 3 were used for bioavailability evaluation. RESULTS: Three deaths were recorded within 24 hours of surgery; a technical problem was identified in all cases and no deaths were the results of raltitrexed toxicity. A peritoneo-plasma gradient of 100:1 was obtained. Cmax in plasma were of 28 ng/ml and 54 ng/ml for group 1 and 2, respectively. Tmax were 180 min for both groups. AUCplasmatic was double in the 2 mg group compared to the 1 mg group. CONCLUSIONS: Raltitrexed administered by IP route in pigs is non-toxic. Pharmacologically, there are few interindividual variations and the small first-past effect did not significantly alter the high peritoneo-plasmatic gradient

Keywords: Antimetabolites, Antineoplastic - pharmacokinetics, Antimetabolites, Antineoplastic - toxicity, Enzyme Inhibitors - pharmacokinetics, Neoplasms - metabolism, Quinazolines - pharmacokinetics, Quinazolines - toxicity, Thiophenes - pharmacokinetics, Thiophenes - toxicity

Add Comment 0 Comments

Editorial

01 June 2024 : Editorial  

Editorial: Concerns as Highly Pathogenic Avian Influenza (HPAI) Virus of the H5N1 Subtype is Identified in Dairy Cows and Other Mammals

Dinah V. Parums

DOI: 10.12659/MSM.945315

Med Sci Monit 2024; 30:e945315

0:00

In Press

Review article  

Impact of Workplace Bullying on Nursing Care Quality: A Comprehensive Review

Med Sci Monit In Press; DOI: 10.12659/MSM.944815  

Clinical Research  

Anterior Plate-Supported Cannulated Screw Surgery for Ankle Arthrodesis: Clinical and Radiologic Results in...

Med Sci Monit In Press; DOI: 10.12659/MSM.944452  

Clinical Research  

Elevated Plasma Levels of Growth Arrest Specific 6 (Gas6) Protein in Severe Obesity: Implications for Adipo...

Med Sci Monit In Press; DOI: 10.12659/MSM.944462  

Database Analysis  

Systemic Immune-Inflammation Index (SII) as a Predictor of Short-Term Mortality Risk in Sepsis-Associated A...

Med Sci Monit In Press; DOI: 10.12659/MSM.943414  

Most Viewed Current Articles

17 Jan 2024 : Review article   2,048,648

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research   1,553,068

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   690,454

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial   50,367

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750